Neurocrine Biosciences
NBIX
#1578
Rank
NZ$22.97 B
Marketcap
NZ$230.44
Share price
-1.16%
Change (1 day)
9.54%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company